Colorectal Neoplasms: all 5,738 studies
Page 14 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal CancerRecruitingNCT05093907Phase 1/2
- Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid TumorsRecruitingNCT05089266Phase 1
- A Beta-only IL-2 ImmunoTherapY StudyRecruitingNCT05086692Phase 1/2
- Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal CancerRecruitingNCT05086614Phase 3
- Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRCRecruitingNCT05077839Phase 2
- Early Detection of Treatment Failure in Metastatic Colorectal Cancer PatientsRecruitingNCT05068531
- The Impact of Immune Cell Changes During the Perioperative Period on the Prognosis of Patients With Colorectal CancerRecruitingNCT05015296
- Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic ChemotherapyRecruitingNCT05014399
- Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)RecruitingNCT05008809Phase 3
- Trifluridine/ Tipiracil Plus Panitumumab Versus Trifluridine/ Tipiracil Plus Bevacizumab as First-line Treatment of Metastatic Colorectal CancerRecruitingNCT05007132Phase 2
- AB122 Platform StudyRecruitingNCT04999761Phase 1
- Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal CancerRecruitingNCT04991948Phase 1
- Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell ManufacturingRecruitingNCT04981119
- Modifications in Retinal Microvascularization With Targeted Anti-angiogenic Therapy in Colorectal CancerRecruitingNCT04952688Not applicable
- Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal CancerRecruitingNCT04938986Not applicable
- Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid TumorsRecruitingNCT04930432Phase 1/2
- A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)RecruitingNCT04929223Phase 1
- Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality Of Life.RecruitingNCT04925154
- Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon AdenocarcinomasRecruitingNCT04920032Phase 1
- CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer PatientsNot yet recruitingNCT04917289Phase 3
- Treatment Response Prediction System of mCRC Patients Based on CTCNot yet recruitingNCT04917276
- Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRCRecruitingNCT04912765Phase 2
- Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain MetastasesRecruitingNCT04899908Phase 2
- A Trial of Camrelizumab Combined With Microwave Ablation and Chemotherapy in the Treatment of Colorectal Cancer Liver Metastasis/Pulmonary MetastasisNot yet recruitingNCT04888806Phase 2
- DNA Adductomics for Colorectal Cancer InvestigationRecruitingNCT04865601
- PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)RecruitingNCT04854213Not applicable
- Centralized Tumour Board and Secondary Intervention Rate in mCRCNot yet recruitingNCT04852250
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsRecruitingNCT04851119Phase 1/2
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal HistologiesRecruitingNCT04847063Phase 1
- Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal ChemotherapyNot yet recruitingNCT04845490Phase 2
- Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical StudyNot yet recruitingNCT04831528
- Liver Transplantation for Unresectable GIST Liver MetastasesNot yet recruitingNCT04825470Not applicable
- Study of the Safety and Effectiveness of HIFU Combined With REGOTORI for Metastatic Colorectal CancerRecruitingNCT04819516Phase 1
- The Longterm Risk of Advanced Colorectal Neoplasia After Colonoscopy - A Population-based Cohort Study in Hong KongRecruitingNCT04815525
- Changes in Reproductive and Sexual Health in People With Early Onset Colorectal CancerRecruitingNCT04812912
- Plasma Biomarker for Aflibercept in Advanced Colorectal CancerRecruitingNCT04810585Phase 4
- An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment ResponseRecruitingNCT04796818Not applicable
- Collection of Samples USOPTIVAL StudyRecruitingNCT04792684
- mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited MetastasesRecruitingNCT04781270Phase 3
- Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPECRecruitingNCT04779554Phase 2
- Systemic Therapy Sequenced Isolated PALND for mCRCRecruitingNCT04774757Not applicable
- Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid TumorsRecruitingNCT04771520Phase 2
- Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer ScreeningRecruitingNCT04767568Not applicable
- SGM-101 in Colorectal Brain Metastases.RecruitingNCT04755920Phase 2
- Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer OutcomeRecruitingNCT04754672Not applicable
- ctDNA as a Assisted Diagnosis, Early Intervention and Prognostic Marker for Peritoneal Metastases From Colorectal CancerRecruitingNCT04752930Not applicable
- Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer PatientsRecruitingNCT04751435Not applicable
- Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C StudyRecruitingNCT04739072
- Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and ModeratorsRecruitingNCT04722341Not applicable
- A Prospective, Multi-center, Real-world Study of Ovarian Metastatic Colorectal Cancer PatientsRecruitingNCT04716257
- TATE and Pembrolizumab (MK3475) in mCRC and NSCLCRecruitingNCT04701476Phase 2
- Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME TrialRecruitingNCT04693377Not applicable
- 5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.RecruitingNCT04689347Phase 1/2
- Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver MetastasesRecruitingNCT04687631Phase 3
- OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal CancerRecruitingNCT04680260Phase 2
- BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC TreatmentRecruitingNCT04673955
- Biopsy After Radioembolization to Identify Changes in Tumor Cells From the RadiationRecruitingNCT04668872
- Role of Diet on the Microbiome of the Digestive SystemRecruitingNCT04666727
- Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal CancerRecruitingNCT04659382Phase 2
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsRecruitingNCT04657068Phase 1/2
- Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRCRecruitingNCT04653480Phase 2
- The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer SurvivorsRecruitingNCT04624555
- Advanced Therapies for Liver MetastasesRecruitingNCT04622423
- Researching the Effect of Exercise on CancerRecruitingNCT04589468Not applicable
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)RecruitingNCT04585750Phase 1/2
- Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesAvailableNCT04566393
- Microwave Ablation Combined With Chemotherapy for Colorectal Liver Metastases： a Multicenter Cohort StudyNot yet recruitingNCT04562727Not applicable
- Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsRecruitingNCT04557449Phase 1/2
- A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)RecruitingNCT04547166Phase 2/3
- Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal CancerRecruitingNCT04527861Not applicable
- Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal CancerRecruitingNCT04516681Phase 3
- Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal CancerRecruitingNCT04511039Phase 1
- General Practitioners and Participation Rate in ColoRectal Cancer ScreeningRecruitingNCT04492215Not applicable
- Developing Risk Prediction Model and Testing the Effect of Dual Task Walking on Improving Cognitive Function in Patients With Colorectal CancerRecruitingNCT04490733Not applicable
- Collection of Information to Better Understand Young Onset Colorectal CancerRecruitingNCT04489238
- Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid TumorsRecruitingNCT04429542Phase 1
- BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid TumoursRecruitingNCT04421820Phase 1/2
- Locally Advanced Colorectal Cancer and Local Recurrences in Västra GötalandRecruitingNCT04406974
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsRecruitingNCT04373564Phase 4
- Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal CarcinomatosisRecruitingNCT04370925Phase 3
- Effect of CGA for Frail Elderly Patients Operated for Colorectal Cancer - The CRC Frailty-studyRecruitingNCT04358328Not applicable
- Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal CancerRecruitingNCT04339374Not applicable
- mFOLFOXIRI Versus mFOLFOX6 as Adjuvant Chemotherapy for Locally Advanced Colorectal CancerRecruitingNCT04338191Phase 3
- PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerRecruitingNCT04329494Phase 1
- Safety Of ColoRectal Assessment and Tumor Evaluation by Colon Capsule EndoscopyRecruitingNCT04307901
- Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic AdenocarcinomaRecruitingNCT04303403Phase 1
- Social Media for Colorectal Cancer ScreeningEnrolling by invitationNCT04296630Not applicable
- Development and Analysis of a Stool Bank for Cancer PatientsEnrolling by invitationNCT04291755
- Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune InfiltrateRecruitingNCT04262687Phase 2
- Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening ProgramRecruitingNCT04257526Not applicable
- Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)RecruitingNCT04235114Phase 1/2
- QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and SafetyRecruitingNCT04233151Phase 3
- Metarrestin (ML-246) in Subjects With Metastatic Solid TumorsRecruitingNCT04222413Phase 1
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal CancersRecruitingNCT04221893Not applicable
- Prospective Study of Extended Robotic Right Hemicolectomy With Complete Mesocolic Excision for CancerRecruitingNCT04190589Not applicable
- COLO-COHORT (Colorectal Cancer Cohort) StudyRecruitingNCT04185779
- Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal CancerEnrolling by invitationNCT04149613
- Protein Needs StudyRecruitingNCT04144907Not applicable
- Probiotics Combined With Standard Chemotherapy Plus Targeted Therapy in Patients With Metastatic Colorectal CancerNot yet recruitingNCT04131803Not applicable
- Predicting Colorectal Cancer - Tissue Samples to Evaluate Tumour Characteristics and Treatment ResponseRecruitingNCT04130971